J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tannock, L. R.
Right arrow Articles by Chait, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tannock, L. R.
Right arrow Articles by Chait, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 43, 149-157, January 2002
Copyright © 2002 by Lipid Research, Inc.

Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL

Lisa R. Tannocka, Peter J. Littlec, Thomas N. Wightb,d, and Alan Chaita
a Department of Medicine, Box 356426, University of Washington, Seattle, WA 98195-6426
b Department of Pathology, University of Washington, Seattle, WA
c Baker Medical Research Institute, Melbourne, Australia
d Hope Heart Institute, Seattle, WA

Correspondence to: Alan Chait, To whom correspondence should be addressed., achait{at}u.washington.edu (E-mail)

Atherosclerosis is the main cause of morbidity and mortality in diabetes, yet the underlying mechanisms remain unclear. Retention of atherogenic lipoproteins by vascular proteoglycans is thought to play a key role in the development of atherosclerotic lesions. High glucose levels cause a variety of diabetic complications by several mechanisms, including upregulation of the hexosamine pathway. Glucosamine, a component of the hexosamine pathway, is a precursor for the synthesis of glycosaminoglycan components of proteoglycans. This study evaluated whether high glucose or glucosamine supplementation of vascular smooth muscle cells would increase proteoglycan synthesis, leading to increased lipoprotein retention. Aortic smooth muscle cells were exposed to physiologic (5.6 mM) or high (25 mM) glucose levels, such as seen in diabetes, or to glucosamine (12 mM). Extracellular proteoglycans were characterized by sulfate incorporation, molecular sieve chromatography, and SDS-PAGE. LDL interactions were assessed by affinity chromatography and gel mobility shift assay. Proteoglycans synthesized in the presence of high glucose demonstrated no differences in size, sulfate incorporation, or LDL binding affinity compared with proteoglycans synthesized under physiological glucose conditions. However, proteoglycans synthesized in the presence of glucosamine had smaller glycosaminoglycan chains than control proteoglycans with a corresponding decrease in lipoprotein retention.

Thus, glucose and glucosamine have different effects on proteoglycan biosynthesis and different effects on lipoprotein retention. — Tannock, L. R., P. J. Little, T. N. Wight, and A. Chait. Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL. J. Lipid Res. 2002. 43: 149–157.

Supplementary key words: atherosclerosis, biglycan, decorin, glycosaminoglycan, hexosamine, lipoprotein, retention, versican, xyloside


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
R. L. Hull, S. Zraika, J. Udayasankar, R. Kisilevsky, W. A. Szarek, T. N. Wight, and S. E. Kahn
Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro
Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1586 - C1593.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. R. Tannock, E. A. Kirk, V. L. King, R. LeBoeuf, T. N. Wight, and A. Chait
Glucosamine Supplementation Accelerates Early but Not Late Atherosclerosis in LDL Receptor-Deficient Mice
J. Nutr., November 1, 2006; 136(11): 2856 - 2861.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. D. Meyers, L. R. Tannock, T. N. Wight, and A. Chait
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL
J. Lipid Res., November 1, 2003; 44(11): 2152 - 2160.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.